American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer

被引:73
作者
Fernando, Hiran C. [1 ]
Timmerman, Robert [2 ]
机构
[1] Boston Med Ctr, Dept Cardiothorac Surg, Boston, MA 02118 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
关键词
PROSPECTIVE PHASE-II; RADIATION-THERAPY; CLINICAL-OUTCOMES; BRACHYTHERAPY; TRIAL; CARCINOMA; FRAME;
D O I
10.1016/j.jtcvs.2012.06.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the past decade, tremendous interest has arisen in the use of nonoperative therapies for patients with non-small cell lung cancer. Of these therapies, stereotactic body radiotherapy has become established as an effective modality for treating peripheral cancer in medically inoperable patients. Toxicity is low, and the treatment is effective, with excellent local control rates. Several investigators have suggested that stereotactic body radiotherapy could be effective for high-risk operable patients (usually treated with sublobar resection) and even perhaps for standard-risk operable patients (usually treated with lobectomy); however, this is less accepted. A direct comparison of stereotactic body radiotherapy and sublobar resection is difficult for a number of reasons. These include different definitions of recurrence, different populations of patients in these studies (with those undergoing stereotactic body radiotherapy tending to be the medically inoperable group), and different methods of classifying morbidity in the surgical and radiation oncology studies. Imaging follow-up has also not been standardized among the studies. Thus, a randomized study is necessary and timely. Investigators from the American College of Surgeons Oncology Group and the Radiation Therapy and Oncology Group have collaborated to develop a phase III randomized study comparing stereotactic body radiotherapy and sublobar resection (with or without brachytherapy) for high-risk operable patients with non-small cell lung cancer. This study (American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021) has recently opened for accrual. It is hoped that this will help to better define the role of these therapies for patients with non-small cell lung cancer. (J Thorac Cardiovasc Surg 2012; 144:S35-8)
引用
收藏
页码:S35 / S38
页数:4
相关论文
共 20 条
[1]  
[Anonymous], 1995, ANN THORAC SURG
[2]   Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy [J].
Baumann, Pia ;
Nyman, Jan ;
Hoyer, Morten ;
Wennberg, Berit ;
Gagliardi, Giovanna ;
Lax, Ingmar ;
Drugge, Ninni ;
Ekberg, Lars ;
Friesland, Signe ;
Johansson, Karl-Axel ;
Lund, Jo-Asmund ;
Morhed, Elisabeth ;
Nilsson, Kristina ;
Levin, Nina ;
Paludan, Merete ;
Sederholm, Christer ;
Traberg, Anders ;
Wittgren, Lena ;
Lewensohn, Rolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3290-3296
[3]   Image-guided Thermal Ablation of Lung Malignancies [J].
Dupuy, Damian E. .
RADIOLOGY, 2011, 260 (03) :633-655
[4]   STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY [J].
Fakiris, Achilles J. ;
McGarry, Ronald C. ;
Yiannoutsos, Constantin T. ;
Papiez, Lech ;
Williams, Mark ;
Henderson, Mark A. ;
Timmerman, Robert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :677-682
[5]   Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer [J].
Fernando, HC ;
Santos, RS ;
Benfield, JR ;
Grannis, FW ;
Keenan, RJ ;
Luketich, JD ;
Close, JM ;
Landreneau, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (02) :261-267
[6]   Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: Results from a multicenter phase III study [J].
Fernando, Hiran C. ;
Landreneau, Rodney J. ;
Mandrekar, Sumithra J. ;
Hillman, Shauna L. ;
Nichols, Francis C. ;
Meyers, Bryan ;
DiPetrillo, Thomas A. ;
Heron, Dwight E. ;
Jones, David R. ;
Daly, Benedict D. T. ;
Starnes, Sandra L. ;
Tan, Angelina ;
Putnam, Joe B. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (05) :1143-1151
[7]   The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: Preliminary results from the American College of Surgeons Oncology Group Z4032 Trial [J].
Fernando, Hiran C. ;
Landreneau, Rodney J. ;
Mandrekar, Sumithra J. ;
Hillman, Shauna L. ;
Nichols, Francis C. ;
Meyers, Bryan ;
DiPetrillo, Thomas A. ;
Heron, Dwight ;
Jones, David R. ;
Daly, Benedict D. T. ;
Starnes, Sandra L. ;
Hatter, Jeffrey E. ;
Putnam, Joe B. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (03) :554-562
[8]   Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer [J].
Grills, Inga S. ;
Mangona, Victor S. ;
Welsh, Robert ;
Chmielewski, Gary ;
McInerney, Erika ;
Martin, Shannon ;
Wloch, Jennifer ;
Ye, Hong ;
Kestin, Larry L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :928-935
[9]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[10]  
Luketich J D, 2000, Clin Lung Cancer, V2, P56, DOI 10.3816/CLC.2000.n.018